• Norovirus Exploits NINJ1 for Selective Viral Protein Secreti

  2026-05-06

  This study uncovers how murine norovirus (MNoV) commandeers the membrane rupture protein NINJ1 to selectively export its NS1 protein, revealing a previously unknown, regulated secretion mechanism during infection. The findings clarify the interplay between viral strategies and host cell death machinery, offering new perspectives for the study of unconventional protein secretion pathways.

• hCG-Mediated CXCL10 Regulation via Histone Methylation in De

  2026-05-05

  This study reveals that human chorionic gonadotropin (hCG) suppresses CXCL10 expression in human decidua by inducing H3K27me3 histone methylation at the CXCL10 promoter, primarily through EZH2 activity. These findings highlight a novel epigenetic mechanism by which placental signals modulate maternal immune cell recruitment at the maternal-fetal interface, with significant implications for pregnancy immunology.

• Coumestrol Triggers Ferroptosis in RA Synoviocytes via PMAIP

  2026-05-05

  This study demonstrates that Coumestrol, a phytoestrogen estrogen receptor antagonist, induces ferroptosis in fibroblast-like synoviocytes (FLS) from rheumatoid arthritis (RA) patients by stabilizing mitochondrial PMAIP1 through TRIM3 suppression. The findings illuminate a novel mechanism for controlling synovial inflammation and proliferation in RA, with implications for targeted SERM and nuclear receptor modulation strategies.

• Bufuralol Hydrochloride: Advancing Human-Relevant Cardiovasc

  2026-05-04

  Explore how Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist with partial intrinsic sympathomimetic activity, is redefining cardiovascular pharmacology research. This article integrates mechanistic insight, experimental strategies with human stem cell-derived intestinal organoids, and actionable translational guidance—positioning APExBIO’s Bufuralol (hydrochloride) as a pivotal tool for next-generation β-adrenergic modulation studies.

• 4μ8C: Precision Unfolded Protein Response Inhibitor Workflow

  2026-05-04

  4μ8C (7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde) empowers cancer researchers to dissect ER stress signaling with unmatched selectivity. Discover how to leverage its precise IRE1α RNase inhibition for reproducible, high-fidelity UPR assays and troubleshoot common experimental challenges.

• Cell lysis buffer for WB and IP: Precision Protein Extractio

  2026-05-03

  Unlock reproducible, high-yield protein extraction with Cell lysis buffer for WB and IP, formulated for robust preservation of native complexes across diverse sample types. This guide translates cutting-edge research into actionable workflows, advanced troubleshooting, and protocol optimization for Western blot and immunoprecipitation success.

• Primidone (Mysoline): Dual TRPM3 and RIPK1 Inhibition in Dis

  2026-05-02

  Primidone (Mysoline) acts as a dual inhibitor of TRPM3 cation channels and RIPK1 kinase, supporting its use in epilepsy, neurodevelopmental disorders, and translational disease models. Recent structural and pharmacological evidence clarifies its mechanistic selectivity and guides research protocol parameters.

• RESTRICT-seq Reveals Epigenetic Dependencies in SCC Resistan

  2026-05-02

  The reference study introduces RESTRICT-seq, a time-gated CRISPR screening platform that uncovers temporally dynamic epigenetic dependencies underlying squamous cell carcinoma (SCC) resistance mechanisms. This approach provides new insights into the role of KAT6A and related histone acetyltransferases in oncogene-induced senescence and offers guidance for future epigenetic drug target validation.

• Q-VD(OMe)-OPh: Precision Caspase Inhibition for Apoptosis As

  2026-05-01

  Q-VD(OMe)-OPh streamlines apoptosis research with high specificity, low cytotoxicity, and broad applicability across cancer, neuroprotection, and differentiation models. Its performance advantage over legacy caspase inhibitors empowers researchers to achieve reproducible, interpretable results—even in challenging multi-pathway studies.

• Niclosamide in Modern Cancer Assays: Beyond STAT3 Inhibition

  2026-04-30

  Discover how Niclosamide, a potent STAT3 signaling pathway inhibitor, enables next-generation cancer research. This article uniquely explores its role in advanced in vitro assay design and data interpretation, setting it apart from existing resources.

• Amikacin Sulfate: Precision Workflows for Intracellular Deli

  2026-04-30

  Amikacin Sulfate empowers researchers to tackle non-tuberculous mycobacterial infections with high intracellular efficacy and minimal cytotoxicity. This guide demystifies advanced in vitro and in vivo workflows, highlights troubleshooting strategies, and integrates new insights from peptide origami research to boost translational impact.

• Flubendazole in Mitochondrial Autophagy: Pathways & Precisio

  2026-04-29

  Explore how Flubendazole, a benzimidazole derivative, advances autophagy modulation research by targeting mitochondrial pathways. This article offers a unique, in-depth analysis bridging glutamine metabolism, assay optimization, and emerging insights in cancer and fibrosis models.

• L-Alanyl-L-Glutamine (B8228): Practical Lab Use and Protocol

  2026-04-29

  L-Alanyl-L-Glutamine (SKU B8228) addresses the instability of free L-glutamine in aqueous solutions, providing a reliable dipeptide alternative for protocols requiring sustained support of intestinal barrier function, antioxidant activity, or cell viability. It is best suited for workflows where solubility, stability, and purity are paramount; it is not recommended for applications needing organic solvent compatibility or extended aqueous storage.

• Tin Mesoporphyrin IX: Precision Heme Oxygenase Assay Solutio

  2026-04-28

  Tin Mesoporphyrin IX (chloride) empowers metabolic, virological, and translational researchers to achieve unparalleled precision in modulating heme oxygenase activity. With robust experimental workflows and troubleshooting insights, this guide details how APExBIO’s high-affinity inhibitor streamlines both discovery and advanced applications.

• UHRF1, DNA Methylation, and Super-Enhancer Dynamics in Senil

  2026-04-28

  This study reveals how UHRF1-mediated DNA 5-mC modifications orchestrate super-enhancer redistribution in mesenchymal stem cells, impairing osteogenesis in senile osteoporosis through TGM2-regulated autophagic flux. The findings provide a mechanistic link between epigenetic regulation, enhancer landscape, and bone loss, highlighting new avenues for targeted epigenetics research and potential therapeutic intervention.

449 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page